Chinese media tested the driver-assist systems of 36 cars in real highway situations and had a wide range in results, but Tesla fared well.

The AMA has granted and assigned Cardio Diagnostics a dedicated CPT® PLA for the company’s AI-driven CHD event risk assessment test, Epi+Gen CHD.